ReviewAnnals of hematology2024

Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders.

Midori ShimaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.